Impact of treatment with long‑acting injectable antipsychotics on hospitalization and relapse rates in schizophrenia spectrum disorders: a 3‑year follow-up mirror‑image study
This study highlights the effectiveness of LAIs as a maintenance treatment for SSDs, particularly for patients with longer LAI treatment duration. Future research may further identify the clinical characteristics of individuals with SSDs who may benefit most from LAI treatment.
Authors
- Matteo Aloi (ORCID: https://orcid.org/0000-0001-5585-6488)
- Georgios Schoretsanitis (ORCID: https://orcid.org/0000-0002-3851-4117)
- Ettore D’Onofrio (ORCID: https://orcid.org/0009-0008-8665-3649)
- Renato de Filippis
- Marianna Rania
- Alfredo Cimino
- Pasquale De Fazio
- Elvira Anna Carbone
- John M. Kane
Institutions
- University of Messina (IT)
- Northwell Health (US)
- Hofstra University (US)
- University of Zurich (CH)
- Magna Graecia University (IT)
- Dulbecco Telethon Institute (IT)
- University Hospital of Zurich (CH)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Accademia di Belle Arti di Catanzaro (IT)
- Zucker Hillside Hospital (US)
Publication Details
- Journal
- Therapeutic Advances in Psychopharmacology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1177/20451253251403263
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00